AssetRoom

Latest Diamond or Dud Sign In

Search by Algolia

↵ to select ↑↓ to navigate esc to close

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Follow MAXCYTE INC

Get SEC filing alerts via email and in your feed for MAXCYTE INC

MXCT MXCT

MAXCYTE INC

About MAXCYTE INC

MaxCyte, Inc. is a leading cell engineering company specializing in advanced platform technologies for cell and gene therapies. Its proprietary Flow Electroporation technology enables efficient delivery of molecules into cells, supporting biopharmaceutical companies and academic institutions. With a growing market opportunity in cell therapy, MaxCyte's ExPERT platform includes various instruments and disposables. Recent innovations include the acquisition of SeQure Dx, enhancing its service offerings in gene editing assessments.

This description was generated via AI from an annual report. Updated 8 months ago.

maxcyte.com